Signaling pathways in failing human heart muscle cells

Trends in Cardiovascular Medicine

Volumn 7, Issue 5, 1997, Pages 151-160

  Drexler, Helmut ^a   Hasenfuss, Gerd ^b   Holubarsch, Christian ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC STIMULATION; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INOTROPISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0030752529     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00030-3     Document Type: Review

References (77)

1. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M: 1993. Alterations in sarcoplasmatic reticulum gene expression in human heart failure. Circ Res 72:463-469.
2. 1 receptors in failing human heart: relationship to β1-receptor down-regulation [abst]. J Am Coll Cardiol 25:291A.
3. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T: 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90: 347-351.
4. Balligand JL, Kobzik L, Han X, et al.: 1995. Nitric oxide dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270:14,582-14,586.
5. Bax WA, Bruinvels AT, van Suylen R-J, Saxena PR, Hoyer D: 1993. Endothelin receptors in the human coronary artery, ventricle and atrium: a quantitative autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol 348:403-410.
6. Beuckelmann DJ, Näbauer M, Erdmann E: 1992. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85: 1046-1055.
7. Böhm M, Larisch K, Erdmann E, Camps M, Jakobs KH, Gierschik P: 1991. Failure of (32P)-ADP-ribosilation by pertussis toxin to determine Gi alpha content in membranes from various human tissues: improved radioimmunological quantification using the 125I-labeled c-terminal decapeptide of retinal transduction. Biochem J 277:223-229.
8. Brillantes AM, Allen PD, Takakashi T, Izumo S, Marks AR: 1992. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 71:18-26.
9. Bristow MR, Ginsburg R, Minobe W, et al.: 1982. Decreased catecholamine sensitivity and β-adrenergic receptors density in failing human hearts. N Engl J Med 307:205-211.
10. Bristow MR, Hershberger RE, Port JD, Rasmussen R: 1989. β1 and β2 adrenergic receptor mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol 35:295-303.
11. Bristow MR, Minobe WA, Raynolds MV, et al.: 1993. Reduced β1-receptor messenger RNA abundance in the failing human heart. J Clin Invest 92:2737-2745.
12. Brodde E: 1991. β1- and β2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242.
13. Dahlhöf B, Pennert K, Hansson L: 1992. Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertens 5:95-110.
14. Danielsen W, v der Leyen H, Meyer W, et al.: 1989. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol 14:171-173.
15. De Belder AJ, Radomski MW, Why HJF, et al.: 1993. Nitric oxide synthase activities in human myocardium. Lancet 341:84-85.
16. Dostal DE, Baker KM: 1993. Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts. Trends Cardiovasc Med 3:67-74.
17. Drexler H, Kästner S, Strobel A, Studer R, Brodde OE, Hasenfuss G: 1996. Expression, activity and functional significance of endothelial and inducible nitric oxide synthase in the failing human heart [abst]. 94:1-29.
18. Feldman AM, Cates AE, Veazey, et al.: 1988. Increase in the 40,000 mol wt pertussis toxin substrate (G-protein) in the failing human heart. J Clin Invest 82:189-197.
19. Feldmann AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR: 1991. Selective gene expression in failing human heart. Circulation 83:1866-1872.
20. Foults J, Tavolaro O, Antony I, Nitenberg A: 1988. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation 77: 337-344.
21. Friedrich SP, Lorell BH, Rousseau MF, et al.: 1994. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 90: 2761-2771.
22. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR: 1995. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 95:888-894.
23. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM: 1994. Modulation of left ventricular relaxation in isolated ececting heart by endogenous nitric oxide. Am J Physiol 267:H1804-H1813.
24. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF: 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753-6757.
25. Haber HL, Powers ER, Gimple LW, et al.: 1994. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 89:2616-2625.
26. Hajjar RJ, Gwathmey JK: 1992. Cross-bridge dynamics in human ventricular myocardium: regulation of contractility in the failing heart. Circulation 86:1819-1826.
27. Hare JM, Loh E, Creager MA, Colucci WS: 1995. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92:2198-2203.
28. Harrap SB, Dominiczak AF, Fraser R: 1996. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 93:1148-1154.
29. Hartzell HC, Mery PF, Fischmeister R, Szabo G: 1991. Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature 352:573-576.
30. Hasenfuss G, Mulieri LA, Leavitt JB, Allen PD, Haeberle JR, Alpert NR: 1992. Alterations of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res 70:1225-1232.
31. Hasenfuss G, Mulieri LA, Leavitt BJ, Alpert NR: 1994. Influence of isoproterenol on contractile protein function, excitation-contraction coupling, and energy turnover of isolated nonfailing human myocardium. J Mol Cell Cardiol 26:1461-1469.
32. Hasenfuss G, Mulieri LA, Allen PD, Just H, Alpert NR: 1996. Influence of isoproterenol and ouabain on excitation-contraction coupling crossbridge function and energetics in failing human myocardium. Circulation 94: 3155-3160.
33. Haywood GA, Tsao PS, von der Leyen HE, et al.: 1996. Expression of inducible nitric oxide synthase in human failing heart. Circulation 93:1087-1094.
34. Hoit BD, Shao Y, Kinoshita A, Gabel M, Husain A, Walsh RA: 1995. Effects of Angiotensin II generated by an angiotensin converting enzyme-independent pathway of left ventricular performance in the conscious baboon. J Clin Invest 95:1519-1527.
35. Hokimoto S, Yasue H, Fujimoto K, Sakata R, Miyamoto E: 1995. Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. Cardiovasc Res 29:664-669.
36. Hokimoto S, Yasue H, Fujimoto K, et al.: 1996. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation 94:1513-1518.
37. Holubarsch C, Hasenfuss G, Schmidt-Schweda S, et al.: 1993. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. Circulation 88:1228-1237.
38. Kirstein M, Rivet-Bastide M, Hatem S, Banardeau A, Mercadier J-J, Fischmeister R: 1995. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794-802.
39. Lefroy DC, Crake T, del Monte F, et al.: 1996. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol 270:H2060-H2069.
40. Malhotra R, Sadoshima J, Izumo S: 1995. Cardiac myocytes, rather than fibroblasts are the predominant cell type responding to stretch-induced upregulation of the renin-angiotensin-system genes. Circulation 92:I-62.
41. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88:1197-1201.
42. Meyer M, Schillinger W, Pieske B, et al.: 1995. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92:778-784.
43. Minshall RD, Yelamanchi VP, Djokovic A, et al.: 1994. Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ Res 74(3):441-447.
44. Moravec CS, Schluchter MD, Paranandi L: 1990. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation 82:1973-1984.
45. Morgan JP, Raymond EE, Allen PD, Grossman W, Gwathmey J: 1990. Abnormal intracellular calcium handling a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81(Suppl III):21-32.
46. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90:653-657.
47. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR: 1992. Altered myocardial force-frequency relation in human heart failure. Circulation 85:1702-1750.
48. Mulieri LA, Leavitt BJ, Martin BJ, Haeberle JR, Alpert NR: 1993. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forscolin. Circulation 88:2700-2704.
49. Muntz KH, Zhao M, Miller JC: 1994. Down-regulation of myocardial β-adrenoceptors. Cire Res 74:369-375.
50. 2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10,663-10,667.
51. Neri Serneri GG, Boddi M, Coppo M, et al.: 1996. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 94:1886-1893.
52. Nozawa Y, Haruno A, Oda N, et al.: 1994. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J Pharmacol Exp Ther 270:566-571.
53. Paulus WJ, Vantrimpont PJ, Shah AM: 1994. Acute effects of nitric oxide on left ventricular relaxation an diastolic distensibility in human. Circulation 89:2070-2078.
54. Paulus WJ, Vantrimpont PJ, Shah AM: 1995. Paracrine coronary endothelial control of left ventricular function in Humans. Circulation 92:2119-2126.
55. Pieske B, Kretschmann B, et al.: 1995. Alterations in intracellular calcium handling associated with inverse force-frequency relationship in human dilated cardiomyopathy. Circulation 92:1169-1178.
56. Rasmussen RP, Minobe A, Bristow MR: 1990. Calcium antagonist binding studies in failing and nonfailing human ventricular myocardium. Biochem Pharmacol 39:691-696.
57. Regitz-Zagrosek V, Friedel N, Heymann A, et al.: 1995. Regulation, chamber localization, and subtype distribution of angiotensin II teceptors in human hearts. Circulation 91:1461-1471.
58. Riegger GAJ, Muders F, Luchner A: 1996. Neurohumorale regulation bei herzinsuffizienz. Z Kardiol 85(Suppl 6):205-210.
59. 2+-regulatory site of bovine cardiac troponin. J Biol Chem 257:260-263.
60. Rogg H, de Gasparo M, Graedel E, et al.: 1996. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J 17: 1112-1120.
61. Sadoshima J, Xu Y, Slayter HS, Izumo S: 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977-984.
62. Sawa H, Tokuchi F, Mochizuki N, et al.: 1992. Expression of the angiotensinogen gene and localization of its protein in the human heart. Circulation 86:138-146.
63. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95:651-657.
64. Studer R, Reinecke H, Müller B, Holtz J, Just H, Drexler H: 1994a. Increased angiotensin-I converting enzyme gene expression in the failing human heart: quantification by competitive RNA polymerase chain reaction. J Clin Invest 94:301-310.
65. Studer R, Sütsch G, Müller B, Oechslin E, Hess OM, Drexler H: 1994b. Role of pressure-overload and wall stress for cardiac gene expression of angiotensin-I converting enzyme in humans. Circulation 90:I-451.
66. 2+ channel) and calsequestrin genes in the myocardium of patients with endstage heart failure. J Clin Invest 90:927-935.
67. Taylor SS: 1989. CAMP-dependent protein kinase: a model for an enzyme family. J Biol Chem 264:8443-8446.
68. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ: 1993. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87:454-463.
69. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A: 1989. Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab 69:54-66.
70. Urata H, Kinoshita A, Perez DM, et al: 1991. Cloning of the gene and cDNA for human heart chymase. J Biol Chem 266:17,173-17,179.
71. Urata H, Boehm KD, Philip A, et al.: 1993. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91:1269-1281.
72. Urata H, Nishimura H, Ganten D: 1996. Chymase-dependent Angiotensin II Forming System in humans. Am J Hypertens 9:277-284.
73. Von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH: 1994. Renin is not synthesized by cardiac and extrarenal vascular tissues. Circulation 89:458-470.
74. Witcher DR, Kovacs RJ, Schulman H, Cefali DC, Jones LR: 1991. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem 266:11,144-11,152.
75. Yamazaki T, Komuro I, Kudoh S, et al.: 1995. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 77:258-265.
76. Yatani A, Brown AM: 1989. Rapid β-adrenergic modulation of cardiac calcium currents by a fast G protein pathway. Science 245:71-74.
77. Zisman LS, Abraham WT, Meixell GE, et al: 1995. Angiotensin II formation in the intact human heart. J Clin Invest 95:1490-1498.